COVID-19-associated ischemic strokes are more severe and correlate with more severe disability on discharge and increased inpatient death.
Study authors conducted a multinational meta-analysis in SARS-CoV-2 patients to assess the risk of stroke relative to the general population and to identify risk factors of stroke.
The approval was based on data from the phase 3 THALES trial (N=11,016) that compared treatment with ticagrelor plus aspirin to aspirin alone in preventing new stroke events.
Outcomes of transfemoral TAVR for symptomatic severe aortic stenosis were comparable with the self-expanding transcatheter ACURATE neo valve or the CoreValve Evolut valve.
Exposure to air pollution may increase the risk for ischemic stroke in patients with atrial fibrillation (AF).
28.9 percent of young adults not aware of all five stroke symptoms; 2.7 percent not aware of any
Admission for hemorrhagic stroke on weekends versus weekdays tied to higher mortality at both rural, urban hospitals
A new index for multiple chronic conditions was effective for predicting post-stroke functional outcomes and disability/dependency in patients with ischemic stroke.
Daily colchicine treatment may reduce the risk for cardiovascular events in patients with chronic coronary disease.
Neurologic manifestations are common in COVID-19, occurring in 82.3 percent of hospitalized patients.